This statistic shows the top promising pipeline drugs globally for chronic hepatitis B in 2014 , by peak year sales. The peak year sales of GS-9620 (Gilead Science) drug for chronic hepatitis B was almost 385 million US dollars in the year 2014.
Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales
(in million U.S. dollars)
Characteristic
Sales in million US dollars
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlobalData. (January 1, 2016). Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. "Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars)." Chart. January 1, 2016. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. (2016). Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData. "Top Promising Pipeline Drugs for Chronic Hepatitis B as of End-2014, by Peak Year Sales (in Million U.S. Dollars)." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/
GlobalData, Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) Statista, https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/ (last visited July 22, 2024)
Top promising pipeline drugs for chronic hepatitis B as of end-2014, by peak year sales (in million U.S. dollars) [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648839/promising-pipeline-drugs-for-chronic-hepatitis-b/